Price T Rowe Associates Inc Viatris Inc Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Viatris Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 56,823,030 shares of VTRS stock, worth $668 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
56,823,030
Previous 57,884,431
1.83%
Holding current value
$668 Million
Previous $691 Million
12.6%
% of portfolio
0.07%
Previous 0.08%
Shares
15 transactions
Others Institutions Holding VTRS
# of Institutions
1,083Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.65 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.09 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$730 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$676 Million3.55% of portfolio
-
Pacer Advisors, Inc. Malvern, PA38.3MShares$450 Million1.04% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14.2B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...